mHealth Market Size, Trends and Insights By Device (Cardiac Monitors, Hemodynamic Monitors, Neurological Monitors, Respiratory Monitors, Others), By Services (Monitoring Services, Diagnostic Services, Treatment Services), By Application (Cardiovascular, Diabetes, Respiratory, Neurology, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034
Report Snapshot
| Study Period: | 2025-2034 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | North America |
Major Players
- Apple Inc.
- Google LLC
- Fitbit Inc.
- Garmin Ltd.
- Others
Reports Description
As per the mHealth Market analysis conducted by CMI Team, the global mHealth market is expected to record a CAGR of 14.5% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 89.9 Billion. By 2034, the valuation is anticipated to reach USD 304 Billion.
Overview
mHealth (also known as m-health or mhealth), an abbreviation for mobile health, is the practice of medicine and public health using mobile devices. The phrase is most generally used to refer to the use of mobile communication devices, including as mobile phones, tablet computers, and personal digital assistants (PDAs), as well as wearable devices like smart watches, for health services, information, and data gathering.
The mHealth sector has arisen as a sub-segment of eHealth and digital health, involving the use of information and communication technology (ICT) such as computers, mobile phones, communications satellites, patient monitors, and so on, for health services and information. mHealth applications include the use of mobile devices to collect community and clinical health data, the delivery/sharing of healthcare information for practitioners, researchers, and patients, real-time monitoring of patient vital signs, direct care delivery (via mobile telemedicine), and health worker training and collaboration.
Key Trends & Drivers
- Rising smartphones and internet penetration: The mHealth market is growing due to the rising smartphones and internet penetration. This makes it easier for people to access mobile health apps and services, get healthcare from a distance, take more responsibility for their own care, and keep track of and manage their health in real time. With mHealth apps, patients may easily access health care services from a distance, so they don’t have to go to the doctor’s office in person. This is conceivable because a growing number of populations are using smartphones. By 2025, there will be an estimated 7.34 billion of population using smartphones. Increasing number of people are using mHealth solutions since they are so convenient. This is especially true for treating chronic conditions and having remote consultations. Telemedicine, remote patient monitoring, and real-time data transfer can all operate well because high-speed internet, such 4G and 5G networks, is widely available. These innovations make mHealth services better and more widely available, especially in developing nations, so that those who can’t get healthcare may get it.
- Rising prevalence of chronic illness: The mHealth sector is growing quickly because a growing number of people are getting chronic illnesses. Chronic diseases including diabetes, heart problems, cancer, and breathing problems are growing more frequent all over the world. This means that there is a greater need for improved ways to manage these diseases. Almost one in three people around the world has more than one chronic medical problem. This has led to a lot of people using mHealth apps and wearable gadgets that let them keep an eye on and manage these problems from afar. This reduces the number of trips to the hospital while improving patient outcomes by allowing for real-time communication with doctors and personalized treatment. A study by the National Institute of Health found that heart disease is becoming more common around the world. By 2050, the number of people who die from CVD is anticipated to jump from 20.5 million to 35.6 million.
Challenges
- Data privacy and security concerns: People are worried about the privacy and security of their data, which is slowing down the growth of the mHealth business. This is because health information is very private and mobile health apps are being hacked more and more. Cybercriminals want to steal health data because it contains very private information like medical history, prescriptions, and insurance information. Accessing data without permission, data breaches, and transmitting data across networks that aren’t secure are still very dangerous. They can lead to identity theft, fraud, and a lack of confidence in patients. Many mHealth apps also have trouble getting real user consent. They often use “dark patterns” in their designs and send data to servers in other countries to get clearances faster. This makes it harder to follow the law, like GDPR. People are typically apprehensive about providing their data without permission, privacy rules that are hard to grasp, and not knowing how their data is being used. This makes it harder for mHealth solutions to gain more users.
- Limited digital infrastructure in developing regions: Limited digital infrastructure in developing area is expected to hamper the industry growth. Because they make hard to get stable internet, cheap internet access, and regular electricity, all of which are necessary for digital health services to work well. In many developing countries, especially in rural and underdeveloped areas, the internet is slow, power outages happen a lot, and mobile and broadband services are highly expensive. This makes it hard for people to get the most out of mHealth solutions. Because there isn’t any infrastructure, apps and remote monitoring technologies that need solid digital environments are less useful and less likely to work.
Opportunities
- Expansion of wearables device: The growing expansion of wearable devices offers a potential opportunity to drive revenue expansion of the market. They allow a real-time health monitoring, early disease detection, and administration of preventive care. Smartwatches, fitness bands, and biosensors are the example of wearable device that constantly track key things including heart rate, blood oxygen, sleep patterns, glucose levels, and physical activity. This information helps both users and doctors make decisions. Furthermore, consumer awareness for proactive health management drives the industry growth.
- Increasing ageing population: The growing older population is expected to florish the industry expansion as older people need more healthcare and are more likely to get chronic diseases, have trouble moving around, and have health problems related to their age. The United Nations states that by 2050, the number of people around the world who are 60 years old or older will double, reaching around 2.1 billion. This figure indicates how mhealth is necessary for older population over the coming years.
Category Wise Insights
By Device
- Cardiac Monitors: The cardiac monitors segment dominates the market. The segment expansion is driven by the growing cardiac disease around the world and the growing product innovation in the market. For instance, In May 2025, iRhythm Technologies, Inc. announced the commercial launch in Japan of its Zio® long-term continuous ECG monitoring (LTCM) system, commercially introduced in this market as the Zio® ECG Recording and Analysis System.
- Hemodynamic Monitors: The hemodynamic monitors segment is growing at a rapid pace. Healthcare systems are putting more and more effort into reducing readmissions, improving patient outcomes, and using remote monitoring and telehealth. All of these things are good for hemodynamic monitoring devices that can connect to these systems.
- Neurological Monitors: The neurological monitors segment is expected to capture the largest market share. The increased prevalence of illnesses such as traumatic brain injuries (TBI), stroke, epilepsy, Parkinson’s disease, and Alzheimer’s is noteworthy. Early detection, continuous monitoring, and individualized therapy are driving demand for sophisticated neuro-monitoring solutions.
- Respiratory Monitors: The respiratory monitors segment holds prominent revenue share. The segment is driven by increasing prevalence of respiratory diseases, technological advancements, and rising adoption of remote monitoring solutions.
- Others: The others segment includes Remote patient monitoring (RPM), home care support devices and non-traditional medical devices.
By Services
- Monitoring Services: The monitoring services experiencing a significant revenue expansion over the forecast period. The segment expansion is owing to the rising prevalence of chronic illness globally and shift to remote patients monitoring.
- Diagnostic Services: The diagnostic services segment holds the largest market share over the forecast period. Diagnostic services include mobile apps and telemedicine/tele-consultation solutions that enable patients and physicians to do diagnostics and screenings remotely. Mobile diagnostic services, particularly in emerging countries, serve to bridge access gaps in areas with fewer hospitals or diagnostic centers.
- Treatment Services: The treatment services segment captures a prominent revenue share in 2024. Telehealth services’ growth accelerated following the pandemic, allowing people to receive healthcare remotely, enhancing convenience, lowering costs, and boosting healthcare accessible, particularly in underdeveloped areas.
By Application
- Cardiovascular: The cardiovascular segment dominates the sector. The rising prevalence of cardiovascular disease is a main reason for the market growth. For instance, according to the data published by CDC, in 2023, 919,032 people died from cardiovascular disease.
- Diabetes: The diabetes segment growing at a rapid rate. The increasing emphasis on advanced technology such as Real-time monitoring and personalized treatment plans are driving the market growth.
- Respiratory: The respiratory segment holds the largest market share over the projected period. The growth is owing to the advancements in technology. The combination of IoT, AI-enabled remote monitoring, smart inhalers, and connected digital therapies makes it easier to keep an eye on patients in real time and follow their treatment plans, making respiratory care more effective and accessible.
- Neurology: The neurology segment is expanding at the fastest rate. These platforms transformative changes in neurology industry by making it possible to do things like teleconsultations, wearables that monitor the brain, and mobile apps that help with diagnosis, rehabilitation, and tracking illnesses.
- Others: The others segment includes mental health, obesity and weight management, fitness and wellness and women health.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 89.9 Billion |
| Projected Market Size in 2034 | USD 304 Billion |
| Market Size in 2024 | USD 78.5 Billion |
| CAGR Growth Rate | 14.5% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Device, Services, Application and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Regional Analysis
The regional market is divided into North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:
- North America: North America dominates the mHealth market. The regional expansion of the market is attributed to the growing chronic illness particularly in the US. For instance, as per secondary analysis, around 61% US population have CVD by 2050. Furthermore, the presence of major players in the area offers an attractive prospect for the market development and increasing technological advancements are likely to have a lucrative advantage for the market development in the area.
- Europe: Europe holds a significant market share. The regional expansion is driven by the growing aging population. Over 21% of the people in Europe are 65 or older, making it one of the oldest populations in the world. This group of people needs more help with managing chronic diseases, living on their own, and getting care after an acute illness, which all increases the need for mHealth solutions.
- Asia-Pacific: The Asia Pacific is expected to grow at the highest CAGR during the forecast period. This is attributed to the increasing government support and growing aging population. Additionally, the increasing expenditure on healthcare infrastructure drives the market growth in the area.
- LAMEA: The LAMEA area, which includes Latin America, the Middle East, and Africa, is growing significantly over the forecast period. The rising investment in advanced technology and increasing awareness about health and wellness.
Key Developments
The key players operate in the market adopted several strategies including product launch, innovation, merger & acquisition, investment and others. Some of the notable developments are:
- In October 2023, Cedars-Sinai recently launched a mobile health application called Cedars-Sinai Connect app, which utilizes artificial intelligence technology to provide virtual care solutions for different clinical matters. This app enables patients to schedule primary care visits on the same day and offers 24/7 virtual access to medical specialists for urgent treatment.
- In November 2022, Hartford HealthCare entered into a long-term partnership with Google Cloud for the advancement of healthcare systems with improvement in data analytics, digital transformation, and enhancement of delivery care & access.
Leading Players
The mHealth market is highly competitive, with a large number of service providers globally. Some of the key players in the market include:
- Apple Inc.
- Google LLC
- Fitbit Inc.
- Samsung Electronics Co. Ltd.
- Garmin Ltd.
- Philips Healthcare
- Cerner Corporation
- Medtronic plc
- Dexcom Inc.
- Omada Health Inc.
- Livongo Health
- Allscripts Healthcare Solutions Inc.
- IBM Watson Health
- GE Healthcare
- Qualcomm Incorporated
- McKesson Corporation
- Bayer AG
- Nokia Health
- athenahealth Inc.
- Teladoc Health Inc.
- Others
The mHealth Market is segmented as follows:
By Device
- Cardiac Monitors
- Hemodynamic Monitors
- Neurological Monitors
- Respiratory Monitors
- Others
By Services
- Monitoring Services
- Diagnostic Services
- Treatment Services
By Application
- Cardiovascular
- Diabetes
- Respiratory
- Neurology
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global MHealth Market, (2024 – 2033) (USD Billion)
- 2.2 Global MHealth Market: snapshot
- Chapter 3. Global MHealth Market – Industry Analysis
- 3.1 MHealth Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing penetration of 4G networks
- 3.2.2 Rise in prevalence of chronic cardiac diseases
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porters Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Device Type
- 3.7.2 Market Attractiveness Analysis By Service
- 3.7.3 Market Attractiveness Analysis By Application
- Chapter 4. Global MHealth Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global MHealth Market: Company Market Share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global MHealth Market – Device Type Analysis
- 5.1 Global MHealth Market Overview: By Device Type
- 5.1.1 Global MHealth Market Share, By Device Type, 2022 and – 2033
- 5.2 Cardiac Monitors
- 5.2.1 Global MHealth Market by Cardiac Monitors, 2024 – 2033 (USD Billion)
- 5.3 Hemodynamic Monitors
- 5.3.1 Global MHealth Market by Hemodynamic Monitors, 2024 – 2033 (USD Billion)
- 5.4 Neurological Monitors
- 5.4.1 Global MHealth Market by Neurological Monitors, 2024 – 2033 (USD Billion)
- 5.5 Respiratory Monitors
- 5.5.1 Global MHealth Market by Respiratory Monitors, 2024 – 2033 (USD Billion)
- 5.6 Temperature Monitors
- 5.6.1 Global MHealth Market by Temperature Monitors, 2024 – 2033 (USD Billion)
- 5.7 Other
- 5.7.1 Global MHealth Market by Other, 2024 – 2033 (USD Billion)
- 5.1 Global MHealth Market Overview: By Device Type
- Chapter 6. Global MHealth Market – Service Analysis
- 6.1 Global MHealth Market Overview: By Service
- 6.1.1 Global MHealth Market Share, By Service, 2022 and – 2033
- 6.2 Monitoring Services
- 6.2.1 Global MHealth Market by Monitoring Services, 2024 – 2033 (USD Billion)
- 6.3 Diagnostic Services
- 6.3.1 Global MHealth Market by Diagnostic Services, 2024 – 2033 (USD Billion)
- 6.4 Treatment Services
- 6.4.1 Global MHealth Market by Treatment Services, 2024 – 2033 (USD Billion)
- 6.1 Global MHealth Market Overview: By Service
- Chapter 7. Global MHealth Market – Application Analysis
- 7.1 Global MHealth Market Overview: By Application
- 7.1.1 Global MHealth Market Share, By Application, 2022 and – 2033
- 7.2 Cardiovascular
- 7.2.1 Global MHealth Market by Cardiovascular, 2024 – 2033 (USD Billion)
- 7.3 Diabetes
- 7.3.1 Global MHealth Market by Diabetes, 2024 – 2033 (USD Billion)
- 7.4 Respiratory
- 7.4.1 Global MHealth Market by Respiratory, 2024 – 2033 (USD Billion)
- 7.5 Neurology
- 7.5.1 Global MHealth Market by Neurology, 2024 – 2033 (USD Billion)
- 7.6 Others
- 7.6.1 Global MHealth Market by Others, 2024 – 2033 (USD Billion)
- 7.1 Global MHealth Market Overview: By Application
- Chapter 8. MHealth Market – Regional Analysis
- 8.1 Global MHealth Market Regional Overview
- 8.2 Global MHealth Market Share, by Region, 2022 & – 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America MHealth Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America MHealth Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America MHealth Market, 2024 – 2033 (USD Billion)
- 8.4 North America MHealth Market, by Device Type, 2024 – 2033
- 8.4.1 North America MHealth Market, by Device Type, 2024 – 2033 (USD Billion)
- 8.5 North America MHealth Market, by Service, 2024 – 2033
- 8.5.1 North America MHealth Market, by Service, 2024 – 2033 (USD Billion)
- 8.6 North America MHealth Market, by Application, 2024 – 2033
- 8.6.1 North America MHealth Market, by Application, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe MHealth Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe MHealth Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe MHealth Market, 2024 – 2033 (USD Billion)
- 8.8 Europe MHealth Market, by Device Type, 2024 – 2033
- 8.8.1 Europe MHealth Market, by Device Type, 2024 – 2033 (USD Billion)
- 8.9 Europe MHealth Market, by Service, 2024 – 2033
- 8.9.1 Europe MHealth Market, by Service, 2024 – 2033 (USD Billion)
- 8.10 Europe MHealth Market, by Application, 2024 – 2033
- 8.10.1 Europe MHealth Market, by Application, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific MHealth Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific MHealth Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific MHealth Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific MHealth Market, by Device Type, 2024 – 2033
- 8.12.1 Asia Pacific MHealth Market, by Device Type, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific MHealth Market, by Service, 2024 – 2033
- 8.13.1 Asia Pacific MHealth Market, by Service, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific MHealth Market, by Application, 2024 – 2033
- 8.14.1 Asia Pacific MHealth Market, by Application, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America MHealth Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America MHealth Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America MHealth Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America MHealth Market, by Device Type, 2024 – 2033
- 8.16.1 Latin America MHealth Market, by Device Type, 2024 – 2033 (USD Billion)
- 8.17 Latin America MHealth Market, by Service, 2024 – 2033
- 8.17.1 Latin America MHealth Market, by Service, 2024 – 2033 (USD Billion)
- 8.18 Latin America MHealth Market, by Application, 2024 – 2033
- 8.18.1 Latin America MHealth Market, by Application, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa MHealth Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa MHealth Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa MHealth Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa MHealth Market, by Device Type, 2024 – 2033
- 8.20.1 The Middle-East and Africa MHealth Market, by Device Type, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa MHealth Market, by Service, 2024 – 2033
- 8.21.1 The Middle-East and Africa MHealth Market, by Service, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa MHealth Market, by Application, 2024 – 2033
- 8.22.1 The Middle-East and Africa MHealth Market, by Application, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Apple Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Google LLC
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Fitbit Inc.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Samsung Electronics Co. Ltd.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Garmin Ltd.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Philips Healthcare
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Cerner Corporation
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Medtronic plc
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Dexcom Inc.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Omada Health Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Livongo Health
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Allscripts Healthcare Solutions Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 IBM Watson Health
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 GE Healthcare
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Qualcomm Incorporated
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 McKesson Corporation
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Bayer AG
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Nokia Health
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 athenahealth Inc.
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Teladoc Health Inc.
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Apple Inc.
List Of Figures
Figures No 1 to 29
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Apple Inc.
- Google LLC
- Fitbit Inc.
- Samsung Electronics Co. Ltd.
- Garmin Ltd.
- Philips Healthcare
- Cerner Corporation
- Medtronic plc
- Dexcom Inc.
- Omada Health Inc.
- Livongo Health
- Allscripts Healthcare Solutions Inc.
- IBM Watson Health
- GE Healthcare
- Qualcomm Incorporated
- McKesson Corporation
- Bayer AG
- Nokia Health
- athenahealth Inc.
- Teladoc Health Inc.
- Others
FAQs
The mHealth market is hampered by the concern over data and security.
The mHealth market is being driven by several factor such as increasing chronic disease globally, growing healthcare expenditure, increasing aging population and technological advancements.
The major players are Apple Inc., Google LLC, Fitbit Inc., Samsung Electronics Co. Ltd., Garmin Ltd., Philips Healthcare, Cerner Corporation, Medtronic plc, Dexcom Inc., Omada Health Inc., Livongo Health, Allscripts Healthcare Solutions Inc., IBM Watson Health, GE Healthcare, Qualcomm Incorporated, McKesson Corporation, Bayer AG, Nokia Health, athenahealth Inc. and Teladoc Health Inc.
The Asia Pacific is expected to grow at the highest CAGR during the forecast period.
North America is expected to dominate the mHealth market during the forecast period.
The mHealth market is anticipated to reach US$ 304 billion by 2034 growing at a CAGR of 14.5% from 2025 to 2034.
The mHealth market is expected to record a CAGR of 14.5% during the forecast period growing from USD 78.5 billion in 2024.